Pepfar 3.0's HIV testing policy in Cote d'Ivoire (2014 to 2018): fragmentation, acceleration and disconnection

被引:2
作者
Bekelynck, Anne [1 ,2 ,4 ]
Larmarange, Joseph [2 ,3 ,8 ]
Assoumou, Nelly [4 ]
Danel, Christine [4 ]
Doumbia, Mohamed [5 ]
Kone, Mariatou [5 ]
Kouadio, Alexis [5 ]
Kra, Arsene [4 ]
Niangoran, Serge [4 ]
Ouantchi, Honore [5 ]
Sika, Lazare [6 ]
Carillon, Severine [7 ]
Ingheis, Maxime [7 ]
机构
[1] Treichville Univ Hosp, PAC CI ANRS Res Site Program, Abidjan, Cote Ivoire
[2] Univ Paris 05, Ctr Populat & Developpement Ceped, INSERM, IRD, Paris, France
[3] IRD, Paris, France
[4] PAC CI, Abidjan, Cote Ivoire
[5] Inst Ethnosociol, Abidjan, Cote Ivoire
[6] ENSEA, Cergy, France
[7] Ceped, Paris, France
[8] IRD, Ceped, Paris, France
关键词
Pepfar; HIV testing; Health policy; COP (Country operational Plan); Cote d'Ivoire; Africa; ANTIRETROVIRAL THERAPY; TRANSMISSION; IMPACT; INTERVENTIONS; CRISIS;
D O I
10.1002/jia2.25424
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction HIV Testing and Counselling (HTC) remains a key challenge in achieving control of the HIV epidemic by 2030. In the early 2010s, the President's Emergency Plan for AIDS Relief (Pepfar) adopted targeted HTC strategies for populations and geographical areas most affected by HIV. We examine how Pepfar defined targeted HTC in Cote d'Ivoire, a country with a mixed HIV epidemic, after a decade of expanding HTC services. Methods We explored the evolution of HTC strategies through the Country Operational Plans (COP) of Pepfar during its phase 3.0, from COP 14 to COP 17 (October 2014 to September 2018) in Cote d'Ivoire. We conducted an analysis of the grey literature over the period 2014 to 2018 (Budget & Target Report, Strategic Direction Summary, Sustainability Index and Dashboard Summary, ). We also conducted a qualitative study in Cote d'Ivoire (2015 to 2018) using in-depth interviews with stakeholders in the AIDS public response: CDC/Pepfar (3), Ministry of Health (3), intermediary NGOs (7); and public meeting observations (14). Results Since the COP 14, Pepfar's HIV testing strategies have been characterized by significant variations in terms of numerical, geographical and population targets. While the aim of COP 14 and COP 15 seemed to be the improvement of testing efficacy in general and testing yield in particular, COP 16 and COP 17 prioritized accelerating progress towards the "first 90" (i.e. reducing the proportion of people living with HIV who are unaware of their HIV). A shift was observed in the definition of testing targets, with less focus on the inclusion of programmatic data and feedback from field actors, and greater emphasis on the use of models to estimate and disaggregate the targets by geographical units and sub-populations (even if the availability of data by this disaggregation was limited or uncertain); increasingly leading to gaps between targets and results. Conclusions These trials and tribulations question the real and long-term effectiveness of annually-revised, fragmented strategies, which widen an increasing disparity between the realities of the actors on the ground and the objectives set in Washington.
引用
收藏
页数:7
相关论文
共 42 条
  • [1] [Anonymous], 2011, POLITICAL DECLARATIO
  • [2] Organization of funding for community-based HIV testing in Cote d'Ivoire: potentially counterproductive search for efficiency?
    Assoumou, A. A.
    Bekelynck, A.
    Carillon, S.
    Kouadio, B. A.
    Ouantchi, H.
    Doumbia, M.
    Larmarange, J.
    Kone, M.
    [J]. MEDECINE ET SANTE TROPICALES, 2019, 29 (03): : 287 - 293
  • [3] Long-term financing needs for HIV control in sub-Saharan Africa in 2015-2050: a modelling study
    Atun, Rifat
    Chang, Angela Y.
    Ogbuoji, Osondu
    Silva, Sachin
    Resch, Stephen
    Hontelez, Jan
    Baernighausen, Till
    [J]. BMJ OPEN, 2016, 6 (03):
  • [4] Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda
    Bunnell, R
    Ekwaru, JP
    Solberg, P
    Wamai, N
    Bikaako-Kajura, W
    Were, W
    Coutinho, A
    Liechty, C
    Madraa, E
    Rutherford, G
    Mermin, J
    [J]. AIDS, 2006, 20 (01) : 85 - 92
  • [5] Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV
    Castilla, J
    del Romero, J
    Hernando, V
    Marincovich, B
    García, S
    Rodríguez, C
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (01) : 96 - 101
  • [6] A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
    Danel, Christine
    Moh, Raoul
    Gabillard, Delphine
    Badje, Anani
    Le Carrou, Jerome
    Ouassa, Timothee
    Ouattara, Eric
    Anzian, Amani
    Ntakpe, Jean-Baptiste
    Minga, Albert
    Kouame, Gerard M.
    Bouhoussou, Franck
    Emieme, Arlette
    Kouame, Antoine
    Inwoley, Andre
    Toni, Thomas-d'Aquin
    Ahiboh, Hugues
    Kabran, Mathieu
    Rabe, Cyprien
    Sidibe, Baba
    Nzunetu, Gustave
    Konan, Romuald
    Gnokoro, Joachim
    Gouesse, Patrice
    Messou, Eugene
    Dohoun, Lambert
    Kamagate, Synali
    Yao, Abo
    Amon, Solange
    Kouame, Amadou-Barenson
    Koua, Aboli
    Kouame, Emmanuel
    Ndri, Yao
    Ba-Gomis, Olivier
    Daligou, Marcelle
    Ackoundze, Simplice
    Hawerlander, Denise
    Ani, Alex
    Dembele, Fassery
    Guehi, Calixte
    Kanga, Constance
    Seri, Jonas
    Oyebi, Mykayila
    Mbakop, Nathalie
    Makaila, Olewole
    Babatunde, Carole
    Babatounde, Nathanael
    Bleoue, Gisele
    Tchoutedjem, Mireille
    Kouadio, Alain-Claude
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (09) : 808 - 822
  • [7] Deborah L Birx: on a mission to end the HIV/AIDS epidemic
    Das, Pamela
    [J]. LANCET, 2016, 388 (10060) : 2583 - 2583
  • [8] The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020
    Dutta, Arin
    Barker, Catherine
    Kallarakal, Ashley
    [J]. PLOS MEDICINE, 2015, 12 (11)
  • [9] PEPFAR'S Past And Future Efforts To Cut Costs, Improve Efficiency, And Increase The Impact Of Global HIV Programs
    Holmes, Charles B.
    Blandford, John M.
    Sangrujee, Nalinee
    Stewart, Scott R.
    DuBois, Amy
    Smith, Tyler R.
    Martin, Julia C.
    Gavaghan, Ann
    Ryan, Caroline A.
    Goosby, Eric P.
    [J]. HEALTH AFFAIRS, 2012, 31 (07) : 1553 - 1560
  • [10] Governmentality and security in the US President's Emergency Plan for AIDS Relief (PEPFAR)
    Ingram, Alan
    [J]. GEOFORUM, 2010, 41 (04) : 607 - 616